COMP <GO>
QNTM vs BYSI // EV/EBITDA & P/E VALUATION
Quantum Biopharma Ltd. Class B Subordinate Voting Shares (NASDAQ) VS. BeyondSpring Inc. (NASDAQ) • 15-METRIC TALLY: QNTM 0
— BYSI 2
■ METRIC PARITY
LAST: $2.44 (+2.95%) • MKT CAP: $20.7M
valuation
—
LAST: $0.52 (-1.49%) • MKT CAP: $21.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QNTM VS. BYSI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QNTM | BYSI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.1 | 54.1 | -18.97 | BYSI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.7M | $21.2M | -$584.2K | BYSI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QNTM REV | BYSI REV | QNTM GROSS % | BYSI GROSS % | QNTM FCF | BYSI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$19.8M |
| FY 2024 | — | $0 | — | — | — | -$16.7M |
| FY 2023 | — | $0 | — | — | — | -$16.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QNTM // BETA —
BYSI // BETA —